2009-08-06 / Local & State

Proven Technology Treating Chronic Sinus Infections Now Available At FCMC

37 million Americans afflicted with sinusitis

A clinically proven, minimally invasive technology for treating chronic sinus inflammation is now available at Fulton County Medical Center. The Balloon Sinuplasty system by Acclarent uses a small catheter and balloon to quickly open and expand blocked sinuses.

Sinusitis is one of the most common chronic health problems in the U.S., afflicting 37 million Americans each year. Patients suffer headaches, congestion, fatigue and other symptoms. This condition significantly impacts an individual's physical, functional and emotional quality of life.

Historically, sinusitis patients were limited to two treatment options: medical therapy such as antibiotics and topical nasal steroids, or conventional sinus surgery such as function endoscopic sinus surgery (FESS). Medical therapy can help alleviate symptoms, as many as 80 percent of patients but is inadequate for the rest. For them, sinus surgery is often the best option. However, FESS is conventional surgery that requires bone and tissue removal in order to open blocked sinus passageways. In lieu of a desired treatment approximately 900,000 patients each year elect to live with painful sinus conditions.

There is an alternative solution in endoscopic sinus surgery with the balloon sinuplasty technology by Acclarent. A small flexible balloon catheter is placed through a nostril into the blocked sinus passageway. The balloon is then inflated to gently restore and open the sinus passageway, restoring normal sinus drainage and function.

Dr. Elliott Bilofsky is the first physician in this area to offer this technology. Dr. Bilofsky says, "The Balloon Sinuplasty devices by Acclarent are a true advance in sinus care, because in many cases it can be done without removing any tissue or bone. That means faster recovery time and less post-procedure discomfort. In fact, many of my patients have been able to return to normal activities within 24 hours and have had significant improvement in the symptoms."

The international , multi-center study, CLEAR 1 published in the prestigious journal Otolaryngology Head and Neck Surgery 2, confirmed at all time points - 24-week, one year and two years - earlier clinical validation that the Balloon Sinuplasty ™ instruments are safe and effective for opening blocked sinuses. The CLEAR study reported:

91.6 percent functional patency rate at one-year; 70 patients (217 sinuses) 3

No serious adverse events at two-years; 65 patients (195 sinuses) 4

Symptom improvement for 85 percent of patients across the two-year post surgery period 5

Sinusitis patients who are considering their option can learn more about the Balloon Sinuplasty technology by Acclarent by calling Dr. Bilofsky's office toll free at 1-866-641- 9550 or by visiting the hospital at www.fcmcpa.org or www.balloonsinuplasty.com.

Return to top